Concepedia

Kevin Markey

KM

12

Publications

317

Citations

11

H-Index

2007

Active since

Affiliations

National Institute for Biological Standards and Control(Current)

Capital Medical University

University of Turku

Turku University Hospital

Statens Serum Institut

Kevin Markey is an author at National Institute for Biological Standards and Control specializing in medicine, immunology, and vaccine development.

ORCID

Top concepts

Publications per year

2007–2020

12

Publications

12

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015

Alex‐Mikael Barkoff, Jussi Mertsola, Denis Piérard et al. · Eurosurveillance · 2019 · 96 citations · Full text

Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015

Alex‐Mikael Barkoff, Jussi Mertsola, Denis Piérard et al. · Journal of Clinical Microbiology · 2018 · 41 citations · Full text

Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells

Thomas J. Mullen, Kevin Markey, Philip G. Murphy et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2007 · 32 citations

, , +5

Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains

Mei Mei Ho, Kevin Markey, Peter Rigsby et al. · Vaccine · 2010 · 25 citations

, , +8

EUVAC.NET collaborative study: Evaluation and standardisation of serology for diagnosis of pertussis

Dorothy Xing, Kevin Markey, Penny Newland et al. · Journal of Immunological Methods · 2011 · 21 citations

, , +6

Rows per page

1–5 of 12